Market Pulse: Crypto markets ripped higher yesterday as Bitcoin and Ethereum surged after President Trump’s mention of digital assets in the State of the Union address, shaking off a recent slump. Banking stocks edged up, led by Scotiabank’s surprise beat across its divisions, while health-tech sentiment drifted on fresh FDA compliance chatter.
Key Movers: Bitcoin and Ethereum grabbed headlines with their rebound, Scotiabank stunned analysts by topping revenue projections, and GameStop saw quiet shifts in its retail-driven trading patterns.
Macro & Politics: Washington’s crypto cheerleading showed how quickly policy cues can fuel rallies, even as looser FDA rules threaten to bog down wearable-health providers in more paperwork.
What’s Next: Watch for any fresh tweets from the White House on digital-asset oversight and monitor crypto funding rates for early signs of a squeeze.
Unfiltered Market Commentary
Everyone’s cheering the crypto bounce after Trump’s SOTU shout-out, but few are pointing at the mounting compliance burden from looser FDA wearable rules (Looser FDA rules for wearables may add to provider burdens, Techtarget.com). That red tape could tie up capital right when digital-asset infrastructure is begging for funding, and nobody’s pricing in the drag.
Look at GameStop’s fading meme momentum (GameStop (GME) Stock Closes at $23.64…, Ibtimes.com.au) alongside negative Bitcoin funding rates flashing in the futures pits (Negative Bitcoin funding rate may signal pending short-squeeze above $70K, Cointelegraph). Both scenes are driven by squeeze dynamics more than underlying value, and one slip in Fed outlook or a rogue tweet can vaporize the froth in seconds.
If you’re still chasing these volatile squeezes, you’re handing the edge to faster algos. Focus instead on bank franchises like Scotiabank that delivered real, across-the-board growth, and scan the BKLN put-option surge (400,000 BKLN put options surge…, The Times of India) for cracks in leveraged-loan ETFs—you’ll find steadier entry points than the latest FOMO wave.
📈 Breaking Financial News
Scotiabank’s Earnings Beat Estimates on Growth Across Units
Bank of Nova Scotia topped estimates on better-than-expected results at its Canadian banking division even as pressure on loans in that business increased.
GameStop (GME) Stock Closes at $23.64 as Meme Momentum Fades and Focus Shifts to Capital Allocation
GameStop Corp. (NYSE: GME) shares closed at $23.64 on Monday, February 23, 2026, up 0.90% from the previous session's $23.43 close, capping a volatile period where the once-dominant meme stock has traded in a narrow range amid fading retail frenzy and renewed…
Bitcoin, Ethereum jump 3% in one day as Trump’s State of the Union address lifts crypto sentiment
Bitcoin and Ethereum saw a 3% surge on Wednesday, driven by positive sentiment following President Trump's State of the Union address. This rebound followed a choppy week, with major altcoins also experiencing gains. The crypto market capitalization rose to …
Novo Nordisk’s Latest Weight Loss Drug Might Be Its Best Yet—and a Much-Needed Win
Over a 24 week period, people on UBT251 lost up to 20% of their body weight on average.
400,000 BKLN put options surge: Is rising software credit risk signaling leveraged loan ETF crash in 2026?
More than 400,000 BKLN put options were bought in just three weeks. That equals about 40 million shares. This is the highest bearish positioning since 2023. The Invesco Senior Loan ETF (BKLN) trades near $20. Software exposure is about 18%. Investors fear ris…
🔍 Market Analysis & Insights
ImmunityBio (IBRX) Stock Explodes 500%+ in 2026 on ANKTIVA's 700% Revenue Surge
ImmunityBio Inc.'s stock has skyrocketed in early 2026, surging more than 500% year-to-date and hitting new 52-week highs above $11 as explosive sales growth for its flagship immunotherapy ANKTIVA, coupled with rapid international regulatory approvals and par…
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm…
Dupixent® (dupilumab) Approved in the U.S. as the First and Only Medicine for Allergic Fungal Rhinosinusitis (AFRS)
Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and symptoms, and systemic corticosteroid use or surgery compared to placebo
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis
Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis Approval in adults and children aged…
Looser FDA rules for wearables may add to provider burdens
The FDA's decision to limit the regulation of certain general wellness wearables could leave clinicians to manage low-quality data risks, including patient anxiety and inaccurate readings.
💰 Investment Opportunities
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
SHENZHEN, CHINA, Feb. 24, 2026 (GLOBE NEWSWIRE) — China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health …
WLFI’s $0.106 under siege: Should traders brace for more losses?
The Congressional investigation and forced market-wide selling in the first week of February saw WLFI drop below a three-month range.
Nvidia’s Q4 results could make or break confidence in the AI hardware market
Nvidia has become shorthand for the AI market itself. In the years since generative models reshaped computing, the company’s GPUs have powered everything from large-scale training clusters to real-time inference infrastructure. That dominance helped Nvidia’s …
Bitcoin market enters full capitulation as price dips below $63K
Panic selling by short-term holders, combined with the RSI near record lows, suggests that BTC could be transitioning into a full capitulation regime.
Negative Bitcoin funding rate may signal pending short-squeeze above $70K
Bitcoin’s range consolidation continues, and a negative funding rate and $3.5 billion short liquidity cluster near $70,000 could serve as fuel for higher if market conditions improve.